FDA Approves Yusimry (adalimumab-aqvh), a Biosimilar to Humira

REDWOOD CITY, Calif., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:“CHRS”,“the Company”,“Coherus”) announced that the United States Food and Drug Administration (“FDA”)...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news